Skip to main content
. 2020 Oct 24;2020(10):CD013256. doi: 10.1002/14651858.CD013256.pub2

El‐Hussuna 2012.

Study characteristics
Methods Retrospective, multicenter (4 institutions) cohort. Study period: 2000 to 2007.
Participants Country: Denmark. CD patients who underwent resection and anastomosis or with stricturoplasty
Interventions 1. Preoperative infliximab/certolizumab (n= 32) within 3 months of surgery
2. Azathioprine/6‐mercaptopurine/methotrexate (n= 166) within 1 month o surgery
3. Preoperative steroids (n= 66)
4. No preoperative anti‐TNF medication (n= 385)
5. No preoperative immunosuppressants (n= 251)
6. No preoperative steroids (n= 351)
Outcomes Intraabdominal septic complications (anastomotic dehiscence, fistula, abscess), septic complications, other infective complications within 30 days of surgery
Notes NOS very high risk of bias overall
Risk of bias
Bias Authors' judgement Support for judgement
Representativeness of the exposed cohort Low risk CD patients who underwent resection form 2000 to 2007
Selection of the non exposed cohort Low risk Both groups obtained from the same hospitals and time period
Ascertainment of exposure Unclear risk No information provided
Demonstration that outcome of interest was not present at start of study High risk 20% patients had preoperative intraabdominal infection
Comparability of cohorts (Controlled for critical factor/other medications) High risk Univariate analysis
Comparability of cohorts (Controlled for additional factor) High risk Univariate analysis
Assessment of outcome Unclear risk No information provided
Was follow‐up long enough for outcomes to occur Low risk 30 days
Adequacy of follow up of cohorts Unclear risk No information provided